PDF) How I treat and monitor non-transfusion-dependent thalassaemia
Haematologica, Volume 102, issue 11 by Haematologica - Issuu
The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
Cells | Free Full-Text | Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia
Cancers | Free Full-Text | Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission - The Lancet Haematology
Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
Frontiers | Understanding blood development and leukemia using sequencing-based technologies and human cell systems
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Vol. 102 No. 5 (2017): May, 2017 | Haematologica
PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient | Scientific Reports
British Journal of Haematology | Wiley Online Library
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development
PDF) Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from 3 decades follow-up in a high-income setting
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM
![PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/44d24730e45badafae7882562e6d62f83daf7632/8-Figure1-1.png "PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar")
PDF] Pathophysiology and treatment of patients with beta-thalassemia – an update | Semantic Scholar
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis | Haematologica
